{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:15:52Z","timestamp":1790702152971,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006366","name":"Minist\u00e9rio da Educa\u00e7\u00e3o","doi-asserted-by":"publisher","award":["88881.064961\/2014\u201301"],"award-info":[{"award-number":["88881.064961\/2014\u201301"]}],"id":[{"id":"10.13039\/501100006366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.tube.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T19:42:28Z","timestamp":1563910948000},"page":"101853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["In silico and in vitro evaluation of tetrahydropyridine compounds as efflux inhibitors in Mycobacterium abscessus"],"prefix":"10.1016","volume":"118","author":[{"given":"Ivy B.","family":"Ramis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia S.","family":"Vianna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lande","family":"Silva Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"von Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Mar\u00e7al","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilo","family":"Zanatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Viveiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro E. Almeida da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2019.07.004_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ats\/idsa statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2019.07.004_bib2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.5588\/ijtld.14.0134","article-title":"Advances in the management of pulmonary disease due to Mycobacterium abscessus complex","volume":"18","author":"Koh","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2019.07.004_bib3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1574-6976.2009.00204.x","article-title":"Indole as an intercellular signal in microbial communities","volume":"34","author":"Lee","year":"2010","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.tube.2019.07.004_bib4","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.07.004_bib5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/fmb.12.63","article-title":"Acquired inducible antimicrobial resistance in Gram-positive bacteria","volume":"7","author":"Chancey","year":"2012","journal-title":"Future Microbiol"},{"key":"10.1016\/j.tube.2019.07.004_bib6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/jcla.21933","article-title":"Resazurin microtiter assay for clarithromycin susceptibility testing of clinical isolates of Mycobacterium abscessus group","volume":"30","author":"Carvalho","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.tube.2019.07.004_bib7","first-page":"2509","article-title":"Resistance to thiacetazone derivatives active against Mycobacterium abscessus involves mutations in the Mmpl5 transcriptional repressor Mab_4384 antimicrob agents","volume":"61","author":"Halloum","year":"2017","journal-title":"Chemotherapy"},{"key":"10.1016\/j.tube.2019.07.004_bib8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijantimicag.2009.06.026","article-title":"Detection of lfra and tap efflux pump genes among clinical isolates of non-pigmented rapidly growing mycobacteria","volume":"34","author":"Esteban","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2019.07.004_bib9","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1128\/AAC.05546-11","article-title":"The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance","volume":"56","author":"schmalstieg","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.07.004_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.biochi.2005.04.012","article-title":"Bacterial efflux systems and efflux pumps inhibitors","volume":"87","author":"Marquez","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.tube.2019.07.004_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","article-title":"Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy","volume":"45","author":"Lomovaskwaya","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.07.004_bib12","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1021\/jm00403a030","article-title":"2-(2-Aryl-2-oxoethylidene)-1,2,3,4-Thps. Novel isomers of 1,4-dihydropyridine calcium channel blockers","volume":"31","author":"Taylor","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2019.07.004_bib13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ijantimicag.2016.11.024","article-title":"In vitro and in silico analysis of the efficiency of tetrahydropyridines as drug efflux inhibitors in Escherichia coli","volume":"49","author":"Silva","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2019.07.004_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr Comput Aided Drug Des"},{"key":"10.1016\/j.tube.2019.07.004_bib15","first-page":"1","article-title":"Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard","volume":"31","author":"Clinical And Laboratory Standards Institute","year":"2011","journal-title":"second ed. Clsi document M24-A2"},{"key":"10.1016\/j.tube.2019.07.004_bib16","first-page":"1","article-title":"Synthesis of 1-Arylethyl-2-arylethylamino-5-trifluoroacetyl-1,2,3,4-tetrahydropyridines and potential cell efflux pump inhibition related compounds","author":"Zanatta","year":"2014","journal-title":"J Heterocyclic Chem"},{"key":"10.1016\/j.tube.2019.07.004_bib17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10096-015-2365-2","article-title":"Antimicrobial susceptibility of rapidly growing mycobacteria using the rapid colorimetric method","volume":"34","author":"Ramis","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.tube.2019.07.004_bib18","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis","volume":"46","author":"Palomino","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2019.07.004_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A new rapid and simple non-radioac- tive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3h] thymidine incorporation assay","volume":"170","author":"Ahmed","year":"1994","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.tube.2019.07.004_bib20","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1128\/IAI.67.9.4586-4593.1999","article-title":"Assess- ment of immunity to mycobacterial infection with luciferase reporter constructs","volume":"67","author":"Snewin","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2019.07.004_bib21","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.bmc.2012.02.039","article-title":"Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis","volume":"20","author":"Groblacher","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.tube.2019.07.004_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2015.00330","article-title":"Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant Mycobacterium tuberculosis clinical isolates from Brazil","volume":"6","author":"coelho","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2019.07.004_bib23","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1055\/a-0639-5412","article-title":"Antimicrobial and efflux inhibitor activity of usnic acid against Mycobacterium abscessus","volume":"84","author":"Ramis","year":"2018","journal-title":"Planta Med"},{"key":"10.1016\/j.tube.2019.07.004_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1754-1611-3-18","article-title":"Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli","volume":"3","author":"Paix\u00e3o","year":"2009","journal-title":"J Biol Eng"},{"key":"10.1016\/j.tube.2019.07.004_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-60327-279-7_12","article-title":"Evaluation of efflux activity of bacteria by a semi-automated fluorometric system","volume":"642","author":"Viveiros","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.tube.2019.07.004_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2017.00711","article-title":"Interplay between mutations and efflux in drug resistant clinical isolates of Mycobacterium tuberculosis","volume":"8","author":"Machado","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2019.07.004_bib27","author":"Home"},{"key":"10.1016\/j.tube.2019.07.004_bib29","author":"Putative"},{"key":"10.1016\/j.tube.2019.07.004_bib30","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction and analysis","volume":"10","author":"kelley","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1016\/j.tube.2019.07.004_bib31","series-title":"Amber 14","author":"Case","year":"2014"},{"key":"10.1016\/j.tube.2019.07.004_bib32","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14sb: improving the accuracy of protein side chain and backbone parameters from ff99sb","volume":"11","author":"Maier","year":"2015","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.tube.2019.07.004_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J Cheminf"},{"key":"10.1016\/j.tube.2019.07.004_bib35","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Autodock 4 and Autodocktools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.tube.2019.07.004_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Autodock Vina: improving the speed and accuracy of docking with a new scoring function, efficientoptimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.tube.2019.07.004_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"Ligplot: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng"},{"key":"10.1016\/j.tube.2019.07.004_bib38","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.febslet.2006.01.074","article-title":"Blind docking of drug-sized compounds to proteins with up to a thousand residues","volume":"580","author":"Het\u00e9nyi","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.tube.2019.07.004_bib39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1021\/ic061541d","article-title":"Synthesis, structure, and activity of supramolecular mimics for the active site and arg 141 residue of copper, zinc-superoxide dismutase","volume":"46","author":"zhou","year":"2007","journal-title":"Inorg Chem"},{"key":"10.1016\/j.tube.2019.07.004_bib40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijantimicag.2014.06.001","article-title":"Alkaloids: an overview of their antibacterial, antibiotic-enhancing and antivirulence activities","volume":"44","author":"Cushinie","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2019.07.004_bib41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejmech.2016.09.034","article-title":"Tetracyclic indolines as a novel class of b-lactam-selective resistance-modifying agent for Mrsa","volume":"125","author":"Zhu","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2019.07.004_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejmech.2017.04.003","article-title":"Indoles as therapeutics of interest in medicinal chemistry: bird's eye view","volume":"134","author":"Chadha","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2019.07.004_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-695X.2011.00831.x","article-title":"Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis","volume":"63","author":"Silva","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.tube.2019.07.004_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tube.2017.08.001","article-title":"Mmps5\/Mmpl5 as an efflux pump in Mycobacterium species","volume":"107","author":"Briffotaux","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2019.07.004_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2017.00681","article-title":"New insights in to the intrinsic and acquired drug resistance mechanisms in mycobacteria","volume":"8","author":"Nasiri","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2019.07.004_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/dkv316","article-title":"Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance Tb therapy","volume":"71","author":"Pule","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2019.07.004_bib47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/0970-2113.217567","article-title":"Effect of efflux pump inhibitors on the susceptibility of Mycobacterium tuberculosis to isoniazid","volume":"34","author":"jaiswal","year":"2017","journal-title":"Lung India"},{"key":"10.1016\/j.tube.2019.07.004_bib48","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jgar.2018.12.020","article-title":"Tetrahydropyridine derivative as efflux inhibitor in Mycobacterium abscessus","volume":"17","author":"vianna","year":"2019","journal-title":"J Glob Antimicrob Resist"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979219300654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979219300654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:42:58Z","timestamp":1761468178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979219300654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":46,"alternative-id":["S1472979219300654"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2019.07.004","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico and in vitro evaluation of tetrahydropyridine compounds as efflux inhibitors in Mycobacterium abscessus","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101853"}}